Provided herein are improved delivery systems foroligonucleotides, said delivery system comprising a liposome that comprisesneutralphospholipids and a P-ethoxy oligonucleotide, which targets anIGF-1R-encoding polynucleotide. Methods of treating patients with saiddelivery systems arealso provided.